2017 The new Capital, page-571

I am happy to stay with CAJ for another two years. This time last year we were 13c and went lower. So 100% appreciation in a year - not unreasonable for a period of consolidation now (much as we would all like to see it rampaging back over a $.)

2018 should see some good things like a few new clinics opening, a dividend reinstated and in May the debt paid off. Chinese clinics should also start operating. Fy 2019 will see the benefits of all this. Plus in 2019 we might see some real advancement with Enlitic.

Will the share price increase enough to make it worthwhile waiting? No idea - to me it should, but markets are unpredictable. However the dividend will help. It is tempting to take the 30% profit I am sitting on and move to another stock, however I make a lot of mistakes, so no guarantee I will do better. I prefer to stick with something that has decent long term prospects and that I feel I understand well.